You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis

Article info

Article menu

Download PDFPDF

Congenital heart disease
Original research article
Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis

Authors

  • Oliver Monfredi University of Manchester, Institute of Cardiovascular Sciences, Manchester, UK Manchester Heart Centre, Manchester Royal Infirmary, UK Laboratory of Cardiovascular Science, National Institute on Aging—Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Elliot Heward University of Manchester, Institute of Cardiovascular Sciences, Manchester, UK PubMed articlesGoogle scholar articles
  • Linda Griffiths Manchester Heart Centre, Manchester Royal Infirmary, UK PubMed articlesGoogle scholar articles
  • Robin Condliffe Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK PubMed articlesGoogle scholar articles
  • Vaikom S Mahadevan University of Manchester, Institute of Cardiovascular Sciences, Manchester, UK Manchester Heart Centre, Manchester Royal Infirmary, UK Heart and Vascular Center, University of California, San Francisco, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Vaikom S Mahadevan; vmahadevan{at}medicine.ucsf.edu
View Full Text

Citation

Monfredi O, Heward E, Griffiths L, et al
Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis
Open Heart 2016;3:e000399. doi: 10.1136/openhrt-2016-000399

Publication history

  • Received January 5, 2016
  • Accepted February 24, 2016
  • First published April 15, 2016.
Online issue publication 
April 30, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/